1. Guest editor's note

   EditorialNotes Pages: 1 - 4

2. Alternative mechanisms of action of anti-oestrogens

   • Anthony A. Colletta
   • John R. Benson
   • Michael Baum

   OriginalPaper Pages: 5 - 9

3. Studies of tamoxifen as a promoter of hepatocarcinogenesis in female Fischer F344 rats

   • Yvonne P. Dragan
   • Susan Fahey
   • Henry C. Pitot

   OriginalPaper Pages: 11 - 25

4. What do we know and what don't we know about tamoxifen in the human uterus

   • Andreas Friedl
   • V. Craig Jordan

   OriginalPaper Pages: 27 - 39

5. Molecular mechanisms of antiestrogen action in breast cancer

   • V. Craig Jordan

   OriginalPaper Pages: 41 - 52

6. Identification and management of the woman at increased risk for breast cancer development

   • Monica Morrow

   OriginalPaper Pages: 53 - 60

7. Antiestrogen action and growth factor regulation

   • Leigh C. Murphy

   OriginalPaper Pages: 61 - 71

8. The Royal Marsden Hospital pilot tamoxifen chemoprevention trial

   • T. J. Powles
   • A. L. Jones
   • J. B. Davey

   OriginalPaper Pages: 73 - 82

9. Droloxifene, a new antiestrogen: Its role in metastatic breast cancer

   • Winrich Rauschning
   • Kathleen I. Pritchard

   OriginalPaper Pages: 83 - 94

10. Antiestrogen regulation of cell cycle progression and cyclin D1 gene expression in MCF-7 human breast cancer cells

    • Colin K. W. Watts
    • Kimberley J. E. Sweeney
    • Robert L. Sutherland

    OriginalPaper Pages: 95 - 105

11. Regulation of insulin-like growth factors by antiestrogen

    • Robert Winston
    • Pai C. Kao
    • David T. Kiang

    OriginalPaper Pages: 107 - 115

12. Characterization of tamoxifen stimulated MCF-7 tumor variants grown in athymic mice

    • Douglas M. Wolf
    • V. Craig Jordan

    OriginalPaper Pages: 117 - 127

13. The estrogen receptor from a tamoxifen stimulated MCF-7 tumor variant contains a point mutation in the ligand binding domain

    • Douglas M. Wolf
    • V. Craig Jordan

    OriginalPaper Pages: 129 - 138